The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomas (HGGs).
 
Sonikpreet Aulakh
Consulting or Advisory Role - Tempus
Speakers' Bureau - Novocure
 
Joanne Xiu
Employment - Caris Life Sciences
 
Pavel Brodskiy
Employment - Caris Life Sciences
 
Ekokobe Fonkem
Honoraria - Bayer; Monteris Medical
Consulting or Advisory Role - Novocure
Research Funding - Abbvie (Inst); Nativis (Inst); Novocure (Inst)
Patents, Royalties, Other Intellectual Property - Global Cancer Technology (Inst)
 
Sourat Darabi
Honoraria - OncoLens
Consulting or Advisory Role - Bayer
 
Michael J. Demeure
Consulting or Advisory Role - Bayer; Loxo/Lilly; OnCusp Therapeutics; Orphagen Pharmaceuticals; Pfizer; TD2; Theralink
(OPTIONAL) Uncompensated Relationships - transmed7
 
Soma Sengupta
Patents, Royalties, Other Intellectual Property - I have patents but receive no royalties from them.
 
Santosh Kesari
Stock and Other Ownership Interests - xcures
Honoraria - Jubilant Biosys; Pyramid Biosciences
Consulting or Advisory Role - biocept; iCAD; xcures
Research Funding - AIVITA Biomedical, Inc. (Inst); Bayer (Inst); Biocept (Inst); Blue Earth Diagnostics (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Caris MPI (Inst); cns pharmaceuticals (Inst); EpicentRx (Inst); Lilly (Inst); Oblato (Inst); Orbus therapeutics (Inst)
 
David M. Ashley
Stock and Other Ownership Interests - Diverse Biotech; MAIA Biotechnology
Consulting or Advisory Role - Jackson Laboratory for Genomic Medicine; MAIA Biotechnology
Patents, Royalties, Other Intellectual Property - Methods for predicting tumor response to immunotherapy, U.S. Provisional application no. 62/787,508 filed January 2, 2019 Methods for predicting tumor response to immunotherapy, U.S. Provisional application no. 62/620,577 filed January 23, 2018
 
Ashley Love Sumrall
Stock and Other Ownership Interests - Novocure (I)
Honoraria - Cardinal Health; Curio Science; Gerson Lehrman Group
Consulting or Advisory Role - Abbvie; Amgen; Athenex; Bayer; Exelixis; Merck; Novocure
Speakers' Bureau - Abbvie; Bayer; Bristol-Myers Squibb; Exelixis; Merck; Novocure; Prime Oncology
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Kura Oncology (Inst); Novocure (Inst); Oncoceutics (Inst)
Travel, Accommodations, Expenses - American Association of Neurological Surgeons; Bristol-Myers Squibb; Novocure; Xcenda
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences
 
Michael J. Glantz
Consulting or Advisory Role - Biocept
Research Funding - cns pharmaceuticals (Inst); Denovo Biopharma (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmunoCellular Therapeutics (Inst); Ono Pharmaceutical (Inst); RTOG (Inst); Sunovion (Inst); Triphase Accelerator Corp (Inst); Vascular Biogenics (Inst)
 
David Spetzler
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Caris Life Sciences
Research Funding - Caris Life Sciences
Patents, Royalties, Other Intellectual Property - Caris Life Sciences holds and has pending patents with intellectual property interests relating to health and medicine.
Travel, Accommodations, Expenses - Caris Life Sciences